As shown in Figures 1C–F, high expression of BCL2L1 elevated lung cancer patients death risk [hazard ratio (HR) and 95% confidence intervals (CI) = 1.60(1.38–1.86)], but no similar correlations were found in IGF1R, MAPK8, and FAS. This evidence concerns the gene IGF1R and lung cancer.